Morgan Lewis - Shareholder Activism Defense: What You Need to Know About Having an Activist-Nominated Director on Your Board – January 2019

Watch the recording >>

January 17, 2019
12:00 PM - 01:00 PM ET
09:00 AM - 10:00 AM PT

Please join Morgan Lewis corporate partner and shareholder activism defense practice leader Keith E. Gottfried and corporate partner Sean M. Donahue for the webinar, "Shareholder Activism Defense: What You Need to Know About Having an Activist-Nominated Director Join Your Board."

This 60-minute webinar will provide an overview of why activist investors seek to have their nominees added to boards of directors, the risks and challenges companies face in having activist-nominated directors on their boards of directors, strategies for minimizing such risks, strategies for integrating activist-nominated directors into the board of directors, and steps companies can take now to be prepared for having an activist-nominated director join their board of directors.


Morgan Lewis’s nationally recognized shareholder activism defense practice is ranked near the top of most of the major league tables for activist defense law practices based on the number of publicly disclosed activism defense situations we have been involved in during the relevant period. Our shareholder activism defense practice advises public companies in a wide array of industries with respect to preparing for and/or responding to high-profile proxy contests, special meeting demands, consent solicitations, withhold and vote-no campaigns, shareholder proposals, and other activist shareholder campaigns as well as contests for corporate control and contested M&A situations. Our shareholder activism defense practice also advises on strategies for lessening a company’s vulnerability to activist shareholders, strategic communications, shareholder engagement, board composition enhancement, and board advisory and corporate governance matters.

CLE credit: CLE credit in CA, IL, NY, PA, TX, and VA is currently pending approval. CLE credit in CT, FL, and NJ is pending approval via reciprocity.